Cas:885280-12-6 Ethyl 4-cyclobutyl-3-oxobutanoate manufacturer & supplier

We serve Chemical Name:Ethyl 4-cyclobutyl-3-oxobutanoate CAS:885280-12-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Ethyl 4-cyclobutyl-3-oxobutanoate

Chemical Name:Ethyl 4-cyclobutyl-3-oxobutanoate
CAS.NO:885280-12-6
Synonyms:ethyl 4-cyclobutyl-3-oxobutanoate
Molecular Formula:C10H16O3
Molecular Weight:184.23200
HS Code:2918300090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:43.37000
Exact Mass:184.11000
LogP:1.69890

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like ethyl 4-cyclobutyl-3-oxobutanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 4-cyclobutyl-3-oxobutanoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl 4-cyclobutyl-3-oxobutanoate Use and application,ethyl 4-cyclobutyl-3-oxobutanoate technical grade,usp/ep/jp grade.


Related News: “It’s the achievement of a dream for an Italian company, I had chills,” he told Forbes in a Zoom interview on Thursday. “For the first three or four decades, my grandfather was in start-up mode [without] making money.” rel-(3R,7S)-7-amino-8-chloro-3-(4-methoxyphenyl)-2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinazolin-1-one manufacturers During a conference call Thursday, Wall Street analysts piled into AstraZeneca’s China performance, pressing management on whether the company can sustain its double-digit sales growth in the country. N-[(2S,3R,4R,5S,6R)-2-Benzyloxy-6-benzyloxymethyl-5-((2R,3R,4S,5R,6R)-6-benzyloxymethyl-3,4,5-trihydroxy-tetrahydro-pyran-2-yloxy)-4-((2S,3S,4R,5R,6S)-3,4,5-tris-benzyloxy-6-methyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-3-yl]-acetamide suppliers Over the past few years, China has been offering AstraZeneca bragging rights. But the company’s business in the country is coming to a turning point after being exposed to the government’s price-cutting scheme and local competition—and investors have caught wind. (2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl)-(1-)4)-(2,3,6-tri-O-acetyl-α-D-glucopyranosyl)-(1-)4)-2,3,6-tri-O-acetyl-1-S-acetyl-1-thio-α-D-glucopyranose vendor & factory.